Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bolt Biotherapeutics (BOLT) Operating Expenses (2020 - 2025)

Bolt Biotherapeutics (BOLT) has disclosed Operating Expenses for 6 consecutive years, with $9.6 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 43.34% to $9.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $43.8 million through Dec 2025, down 45.74% year-over-year, with the annual reading at $43.8 million for FY2025, 45.74% down from the prior year.
  • Operating Expenses hit $9.6 million in Q4 2025 for Bolt Biotherapeutics, down from $9.9 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $27.6 million in Q4 2021 to a low of $9.6 million in Q4 2025.
  • Historically, Operating Expenses has averaged $19.9 million across 5 years, with a median of $21.6 million in 2023.
  • Biggest five-year swings in Operating Expenses: soared 112.59% in 2021 and later plummeted 53.86% in 2025.
  • Year by year, Operating Expenses stood at $27.6 million in 2021, then fell by 18.61% to $22.5 million in 2022, then dropped by 2.65% to $21.9 million in 2023, then fell by 22.6% to $16.9 million in 2024, then plummeted by 43.34% to $9.6 million in 2025.
  • Business Quant data shows Operating Expenses for BOLT at $9.6 million in Q4 2025, $9.9 million in Q3 2025, and $11.0 million in Q2 2025.